Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Hematology/Oncology Clinics of North America
|
February 21, 2018
Gene Therapy and Genome Editing
Farid Boulad, Jorge Mansilla-Soto, Annalisa Cabriolu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 5, 2022
Globin vector regulatory elements are active in early hematopoietic progenitor cells
Annalisa Cabriolu, Ashlesha Odak, Lee Zamparo, et al.
Haematologica
|
January 29, 2011
Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin
Stefania Satta, Lucia Perseu, Paolo Moi, et al.
Nature Medicine
|
January 30, 2019
Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Judith Feucht, Jie Sun, Justin Eyquem, et al.
Nature Medicine
|
December 19, 2018
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Judith Feucht, Jie Sun, Justin Eyquem, et al.
British Journal of Haematology
|
November 20, 2020
Induction of therapeutic levels of HbF in genome-edited primary β<sup>0</sup> 39-thalassaemia haematopoietic stem and progenitor cells
Maura Mingoia, Cristian A Caria, Lin Ye, et al.
Nature
|
March 29, 2019
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
Mohamad Hamieh, Anton Dobrin, Annalisa Cabriolu, et al.
Nature Cancer
|
May 22, 2026
Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases
Sophia Navarre, Maki N Ishibashi, Achuth Nair, et al.
Nature Biomedical Engineering
|
August 8, 2022
Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells
Sjoukje J C van der Stegen, Pieter L Lindenbergh, Roseanna M Petrovic, et al.
Nature Medicine
|
January 4, 2022
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial
Farid Boulad, Aurelio Maggio, Xiuyan Wang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Hematology/Oncology Clinics of North America
|
February 21, 2018
Gene Therapy and Genome Editing
Farid Boulad, Jorge Mansilla-Soto, Annalisa Cabriolu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 5, 2022
Globin vector regulatory elements are active in early hematopoietic progenitor cells
Annalisa Cabriolu, Ashlesha Odak, Lee Zamparo, et al.
Haematologica
|
January 29, 2011
Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin
Stefania Satta, Lucia Perseu, Paolo Moi, et al.
Nature Medicine
|
January 30, 2019
Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Judith Feucht, Jie Sun, Justin Eyquem, et al.
Nature Medicine
|
December 19, 2018
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Judith Feucht, Jie Sun, Justin Eyquem, et al.
British Journal of Haematology
|
November 20, 2020
Induction of therapeutic levels of HbF in genome-edited primary β<sup>0</sup> 39-thalassaemia haematopoietic stem and progenitor cells
Maura Mingoia, Cristian A Caria, Lin Ye, et al.
Nature
|
March 29, 2019
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
Mohamad Hamieh, Anton Dobrin, Annalisa Cabriolu, et al.
Nature Cancer
|
May 22, 2026
Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases
Sophia Navarre, Maki N Ishibashi, Achuth Nair, et al.
Nature Biomedical Engineering
|
August 8, 2022
Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells
Sjoukje J C van der Stegen, Pieter L Lindenbergh, Roseanna M Petrovic, et al.
Nature Medicine
|
January 4, 2022
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial
Farid Boulad, Aurelio Maggio, Xiuyan Wang, et al.
Page
of 1